Page last updated: 2024-12-05
2,4-dimethylpyridine
2,4-Dimethylpyridine is a heterocyclic aromatic compound with the molecular formula C7H9N. It is a colorless liquid with a characteristic pyridine odor. It is primarily used as a starting material for the synthesis of other chemicals, particularly pharmaceuticals. 2,4-Dimethylpyridine is a versatile building block for the synthesis of various pyridine derivatives, including those with medicinal properties. It is also a potential precursor to various polymers and other materials. Its chemical reactivity and structural similarity to natural compounds like vitamin B6 make it an interesting subject for research in areas such as drug discovery and materials science. The compound is known to exhibit antimicrobial activity and has been explored for its potential in treating bacterial infections. Its synthesis is often achieved through a variety of methods, including the reaction of pyridine with methyl halides in the presence of a base. 2,4-Dimethylpyridine has been studied extensively due to its potential applications in various fields, and its synthesis, effects, and importance continue to be areas of active research.'
Cross-References
ID Source | ID |
PubMed CID | 7936 |
CHEBI ID | 192115 |
SCHEMBL ID | 44068 |
MeSH ID | M0210265 |
Synonyms (44)
Synonym |
EN300-19112 |
.alpha.,.gamma.-dimethylpyridine |
nsc-2156 |
nsc2156 |
2,4-dimethylpyridine |
2,4-lutidine |
108-47-4 |
nsc 2156 |
ai3-24281 |
brn 0001506 |
alpha,gamma-dimethylpyridine |
einecs 203-586-8 |
inchi=1/c7h9n/c1-6-3-4-8-7(2)5-6/h3-5h,1-2h |
pyridine, 2,4-dimethyl- |
2,4-lutidine, 99% |
L0085 |
CHEBI:192115 |
AKOS005258307 |
STL280318 |
5-20-06-00019 (beilstein handbook reference) |
83903uj0ww , |
unii-83903uj0ww |
FT-0610233 |
AM20050655 |
2,4-dimethylpyridine [fhfi] |
fema no. 4389 |
BP-30083 |
4,6-dimethyl-pyridine |
2.4-lutidine |
2,4 lutidine |
BBL027575 |
SCHEMBL44068 |
DTXSID2051556 |
W-200785 |
STR07571 |
CS-W020592 |
2,4-lutidene |
AC-26213 |
mfcd00006337 |
2,4-lutidine, analytical standard |
alpha,laquo gammaraquo -dimethylpyridine |
2,4-dimethyl-pyridine |
Q22266828 |
rvv , |
Drug Classes (1)
Class | Description |
methylpyridines | Any member of the class of pyridines that carries at least one methyl substituent. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 32.08
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 32.08 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.54 (4.65) | Search Engine Demand Index | 30.68 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |